Human Normal Immunoglobulin 10 % - BB  100 g/l solution for injection Bulgaria - bulgaro - Изпълнителна агенция по лекарствата

human normal immunoglobulin 10 % - bb  100 g/l solution for injection

БУЛ БИО - НЦЗПБ ЕООД - Имуноглобулин нормален човек за внесосудистого адм. - 100 g/l solution for injection

HyperRho S/D Full dose 1500 IU solution for injection Bulgaria - bulgaro - Изпълнителна агенция по лекарствата

hyperrho s/d full dose 1500 iu solution for injection

Химимпорт Фарма АД - Анти-d (rh) имуноглобулин - solution for injection

Chf - Bulin 120 g/l solution for injection Bulgaria - bulgaro - Изпълнителна агенция по лекарствата

chf - bulin 120 g/l solution for injection

БУЛ БИО - НЦЗПБ ЕООД - Имуноглобулин Човек Анти-Кримеан Хеморагична Треска - 120 g/l solution for injection

Gammanorm 165 mg/ml solution for injection Bulgaria - bulgaro - Изпълнителна агенция по лекарствата

gammanorm 165 mg/ml solution for injection

octapharma (ip) limited - Имуноглобулин нормален човек за администриране на внесосудистого - 165 mg/ml solution for injection

Rhesonativ 625 IU/ml solution for injection Bulgaria - bulgaro - Изпълнителна агенция по лекарствата

rhesonativ 625 iu/ml solution for injection

octapharma (ip) ltd - Анти-d (rh) имуноглобулин - 625 iu/ml solution for injection

Flebogamma DIF (previously Flebogammadif) Unione Europea - bulgaro - EMA (European Medicines Agency)

flebogamma dif (previously flebogammadif)

instituto grifols s.a. - Имуноглобулин нормален човек - mucocutaneous lymph node syndrome; guillain-barre syndrome; bone marrow transplantation; purpura, thrombocytopenic, idiopathic; immunologic deficiency syndromes - Имунни серуми и имуноглобулини - replacement therapy in adults, children and adolescents (0-18 years) in: , primary immunodeficiency syndromes with impaired antibody production;, hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic luekaemia, in whom prophylactic antibiotics have failed;, hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who failed to respond to pneumococcal immunisation;, hypogammaglobulinaemia in patients after allogenic haematopoietic-stem-cell transplantation (hsct);, congenital aids with recurrent bacterial infections. , immunomodulation in adults, children and adolescents (0-18 years) in: , primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, guillain barré syndrome;, kawasaki disease.